BOLDEN African News · Friday 13 November 2026
Pharma 5 launches the first cannabis-based epilepsy medicine made entirely in Morocco
Pharma 5 has launched a cannabis-based medicine for severe epilepsy that does not respond to conventional treatment, using cannabidiol purified to more than 98%. The company says it invested more than MAD 200 million over five years and controls the chain from 20 hectares of regulated cultivation in the Rif to extraction and manufacturing. The project falls under Law 13-21 and involved the cannabis regulator ANRAC and the medicines agency.
Why it matters
It is an early test of whether Morocco's legal cannabis framework can produce medicines made in the country rather than only raw material.
Source: Hespress English · 13 November 2026
